Revive Therapeutics Ltd.
RVV
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.00K | 10.70K | 32.30K | 38.50K | 202.10K |
| Total Receivables | 4.50K | -- | -- | 500.00 | 9.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.60K | 32.20K | 38.50K | 87.70K | 165.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.20K | 7.30K | 7.00K | 13.90K | 14.80K |
| Total Current Assets | 81.30K | 50.20K | 77.80K | 140.60K | 391.80K |
|
|
|||||
| Total Current Assets | 81.30K | 50.20K | 77.80K | 140.60K | 391.80K |
| Net Property, Plant & Equipment | 600.00 | 600.00 | 600.00 | 700.00 | 800.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 6.52M | 6.52M | 6.94M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 179.30K | 150.30K | 6.70M | 6.75M | 7.44M |
|
|
|||||
| Total Accounts Payable | 1.98M | 1.94M | 1.88M | 1.79M | 1.90M |
| Total Accrued Expenses | 601.90K | 635.10K | 577.70K | 463.10K | 472.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.59M | 2.58M | 2.46M | 2.25M | 2.38M |
|
|
|||||
| Total Current Liabilities | 2.59M | 2.58M | 2.46M | 2.25M | 2.38M |
| Long-Term Debt | 48.90K | 49.00K | 45.60K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 58.10K | 58.40K | 57.70K | 57.70K | 58.50K |
| Total Liabilities | 2.69M | 2.68M | 2.56M | 2.31M | 2.43M |
|
|
|||||
| Common Stock & APIC | 51.36M | 52.30M | 49.49M | 49.35M | 52.56M |
| Retained Earnings | -55.62M | -56.60M | -47.03M | -46.58M | -49.34M |
| Treasury Stock & Other | 1.75M | 1.77M | 1.68M | 1.67M | 1.78M |
| Total Common Equity | -2.51M | -2.53M | 4.13M | 4.44M | 5.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.51M | -2.53M | 4.13M | 4.44M | 5.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.51M | -2.53M | 4.13M | 4.44M | 5.00M |
|
|
|||||